Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Bio Sequence
3 min read
Exploring the World of Sequence IP with Patsnap Bio
12 October 2023
In the rapidly escalating field of biological research, the importance of intellectual property (IP) has never been more critical. With biological sequences becoming paramount in the biotech and pharmaceutical sectors, the advent of a convenient, comprehensive patent search database is indeed a significant breakthrough.
Drug Insights
5 min read
Exploring alefacept's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
11 October 2023
This article summarized the latest R&D progress of alefacept, the Mechanism of Action for alefacept, and the drug target R&D trends for alefacept.
Latest Hotspot
3 min read
Geron Reports Validation by EMA of Marketing Approval Submission for Imetelstat
11 October 2023
Geron Corporation declared that the Marketing Authorization Application concerning imetelstat-a novel experimental telomerase inhibitor-has been accepted and validated by the EMA.
Drug Insights
4 min read
Decoding ajmaline: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
11 October 2023
This article summarized the latest R&D progress of ajmaline, the Mechanism of Action for ajmaline, and the drug target R&D trends for ajmaline.
Bio Sequence
2 min read
Investigating Sequence Modifications: An Exploration with Patsnap Bio Sequence Database
11 October 2023
To undertake a detailed exploration of sequence modifications and comprehend the associated specific patent information, we propose utilizing the Patsnap Bio sequence database. Boasting an extensive archive of patent literature and affiliated sequence data, this bio-database forms an invaluable tool for a thorough investigation.
Drug Insights
5 min read
Deep Scientific Insights on acetylcholine chloride's R&D Progress, Mechanism of Action, and Drug Target
11 October 2023
This article summarized the latest R&D progress of acetylcholine chloride, the Mechanism of Action for acetylcholine chloride, and the drug target R&D trends for acetylcholine chloride.
Latest Hotspot
3 min read
FDA approves priority review of Odronextamab BLA for relapsed/refractory follicular and diffuse large B-cell lymphoma
11 October 2023
FDA accepts Priority Review of Odronextamab BLA for Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma.
Drug Insights
4 min read
An In-depth Analysis of acetaminophen/butalbital/caffeine's R&D Progress
11 October 2023
This article summarized the latest R&D progress of acetaminophen/butalbital/caffeine, the Mechanism of Action for acetaminophen/butalbital/caffeine, and the drug target R&D trends for acetaminophen/butalbital/caffeine.
Advanced Tech.
6 min read
New Hope for Solid Tumor Treatment: TIL Therapy
11 October 2023
TIL therapy uses the patient's own immune cells from the solid tumor microenvironment to kill tumor cells.
Drug Insights
5 min read
carglumic acid: Detailed Review of its Transformative R&D Success
11 October 2023
This article summarized the latest R&D progress of carglumic acid, the Mechanism of Action for carglumic acid, and the drug target R&D trends for carglumic acid.
Latest Hotspot
3 min read
IMUNON Announces Data from Phase 1/2 OVATION 2 Trial for Late-Stage Ovarian Cancer
11 October 2023
IMUNON released preliminary PFS and OS statistics related to IMNN-001 from its Phase 1/2 OVATION 2 Investigation.
Drug Insights
4 min read
Regadenoson: Detailed Review of its Transformative R&D Success
11 October 2023
This article summarized the latest R&D progress of Regadenoson, the Mechanism of Action for Regadenoson, and the drug target R&D trends for Regadenoson.